BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29041934)

  • 1. H syndrome: 5 new cases from the United States with novel features and responses to therapy.
    Bloom JL; Lin C; Imundo L; Guthery S; Stepenaskie S; Galambos C; Lowichik A; Bohnsack JF
    Pediatr Rheumatol Online J; 2017 Oct; 15(1):76. PubMed ID: 29041934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocilizumab for the Treatment of SLC29A3 Mutation Positive PHID Syndrome.
    Rafiq NK; Hussain K; Brogan PA
    Pediatrics; 2017 Nov; 140(5):. PubMed ID: 29079714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H syndrome treated with Tocilizumab: two case reports and literature review.
    Jacquot R; Jouret M; Valentin MG; Richard M; Jamilloux Y; Rousset F; Emile JF; Haroche J; Steinmüller L; Zekre F; Phan A; Belot A; Seve P
    Front Immunol; 2023; 14():1061182. PubMed ID: 37638031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygosity for a novel large deletion in SLC29A3 in a patient with H syndrome.
    Shankar SG; Rangarajan S; Priyadarshini A; Swaminathan A; Sundaram M
    Pediatr Dermatol; 2020 Mar; 37(2):333-336. PubMed ID: 31867772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H syndrome: the first 79 patients.
    Molho-Pessach V; Ramot Y; Camille F; Doviner V; Babay S; Luis SJ; Broshtilova V; Zlotogorski A
    J Am Acad Dermatol; 2014 Jan; 70(1):80-8. PubMed ID: 24172204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two novel mutations in SLC29A3 encoding an equilibrative nucleoside transporter (hENT3) in two distinct Syrian families with H syndrome: expression studies of SLC29A3 (hENT3) in human skin.
    Farooq M; Moustafa RM; Fujimoto A; Fujikawa H; Abbas O; Kibbi AG; Kurban M; Shimomura Y
    Dermatology; 2012; 224(3):277-84. PubMed ID: 22653152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H syndrome: Clinical, histological and genetic investigation in Tunisian patients.
    Jaouadi H; Zaouak A; Sellami K; Messaoud O; Chargui M; Hammami H; Jones M; Jouini R; Chadli Debbiche A; Chraiet K; Fenniche S; Mrad R; Mokni M; Turki H; Benkhalifa R; Abdelhak S
    J Dermatol; 2018 Aug; 45(8):978-985. PubMed ID: 29808591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC29A3 mutation in a patient with syndromic diabetes with features of pigmented hypertrichotic dermatosis with insulin-dependent diabetes, H syndrome and Faisalabad histiocytosis.
    de Jesus J; Imane Z; Senée V; Romero S; Guillausseau PJ; Balafrej A; Julier C
    Diabetes Metab; 2013 May; 39(3):281-5. PubMed ID: 23623699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, Histochemical, and Molecular Study of Three Turkish Siblings Diagnosed with H Syndrome, and Literature Review.
    Simsek E; Simsek T; Eren M; Yilmaz E; Arik D; Cilingir O; Ceylaner S; Harmancı K
    Horm Res Paediatr; 2019; 91(5):346-355. PubMed ID: 30625464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Egyptian family with H syndrome due to a novel mutation in SLC29A3 illustrating overlapping features with pigmented hypertrichotic dermatosis with insulin-dependent diabetes and Faisalabad histiocytosis.
    Elbarbary NS; Tjora E; Molnes J; Lie BA; Habib MA; Salem MA; Njølstad PR
    Pediatr Diabetes; 2013 Sep; 14(6):466-72. PubMed ID: 22989030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel homozygous frame-shift mutation in the SLC29A3 gene: a new case report and review of literature.
    Noavar S; Behroozi S; Tatarcheh T; Parvini F; Foroutan M; Fahimi H
    BMC Med Genet; 2019 Aug; 20(1):147. PubMed ID: 31464584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'H-syndrome': a multisystem genetic disorder with cutaneous clues.
    Mori KS; Balachandran K; Asirvatham AR; Mahadevan S
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33947670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H Syndrome: Report of The First Case in African Ethnicity.
    Elmansour OKA; Babikir AOA
    Cureus; 2022 Mar; 14(3):e23281. PubMed ID: 35449643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation in the SLC29A3 gene: a new cause of a monogenic, autoinflammatory condition.
    Melki I; Lambot K; Jonard L; Couloigner V; Quartier P; Neven B; Bader-Meunier B
    Pediatrics; 2013 Apr; 131(4):e1308-13. PubMed ID: 23530176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The H syndrome is caused by mutations in the nucleoside transporter hENT3.
    Molho-Pessach V; Lerer I; Abeliovich D; Agha Z; Abu Libdeh A; Broshtilova V; Elpeleg O; Zlotogorski A
    Am J Hum Genet; 2008 Oct; 83(4):529-34. PubMed ID: 18940313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ophthalmologic Findings in H Syndrome: A Unique Diagnostic Clue.
    Molho-Pessach V; Mechoulam H; Siam R; Babay S; Ramot Y; Zlotogorski A
    Ophthalmic Genet; 2015; 36(4):365-8. PubMed ID: 24547910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.
    Morgan NV; Morris MR; Cangul H; Gleeson D; Straatman-Iwanowska A; Davies N; Keenan S; Pasha S; Rahman F; Gentle D; Vreeswijk MP; Devilee P; Knowles MA; Ceylaner S; Trembath RC; Dalence C; Kismet E; Köseoğlu V; Rossbach HC; Gissen P; Tannahill D; Maher ER
    PLoS Genet; 2010 Feb; 6(2):e1000833. PubMed ID: 20140240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) syndrome is associated with severe chronic inflammation and cardiomyopathy, and represents a new monogenic autoinflammatory syndrome.
    Senniappan S; Hughes M; Shah P; Shah V; Kaski JP; Brogan P; Hussain K
    J Pediatr Endocrinol Metab; 2013; 26(9-10):877-82. PubMed ID: 23729543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic intrafamilial variability including H syndrome and Rosai-Dorfman disease associated with the same c.1088G > A mutation in the SLC29A3 gene.
    Chouk H; Ben Rejeb M; Boussofara L; Elmabrouk H; Ghariani N; Sriha B; Saad A; H'Mida D; Denguezli M
    Hum Genomics; 2021 Oct; 15(1):63. PubMed ID: 34657628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the clinical spectrum of SLC29A3 gene defects.
    Spiegel R; Cliffe ST; Buckley MF; Crow YJ; Urquhart J; Horovitz Y; Tenenbaum-Rakover Y; Newman WG; Donnai D; Shalev SA
    Eur J Med Genet; 2010; 53(5):309-13. PubMed ID: 20619369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.